Drug recall · July 12, 2023
Tizanidine Tablets recall
Why: Failed Dissolution Specifications: this repackaged product was recalled by the manufacturer, Dr. Reddy's Laboratories, Inc., due to out of specification results for dissolution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tizanidine Tablets, USP, 4 mg, 100 Tablets (10 tablets x 10 unit dose blister packs) per carton, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-645-01 (carton), barcode (01) 003 68084 645 11 2.
- Lots / codes
Lot 1004835, Exp 7/31/2023
- Quantity
- 4,971 cartons
- Company
- Amerisource Health Services LLC, Columbus, OH
- Distribution
- Nationwide in the USA
- Initiated
- June 23, 2023 · Voluntary: Firm initiated
- Classified
- June 30, 2023
- Reported
- July 12, 2023
- Ended
- September 6, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tizanidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.